Author:
Ward Kristy,Carroll Amy R.
Publisher
Springer International Publishing
Reference34 articles.
1. Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B. Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S67–72.
2. American College of Obstetricians and Gynecologists. Lynch syndrome. Practice Bulletin No. 147. Obstet Gynecol. 2014;124:1042–54.
3. Cantrell LA, Havrilesky L, Moore DT, O’Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN, Wallace AH, Rose P, Gehrig PA. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. Gynecol Oncol. 2012;127(1):22.
4. Cowden syndrome – Genetics Home Reference. 2014;1–7.
http://ghr.nlm.nih.gov/condition/cowden-syndrome
. Accessed 20 Jan 14.
5. Creutzberg CL, van Putten WL, Koper PC, Lybert ML, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.